BIOLARGO, INC. — fact timeline

Source-grounded facts extracted from BIOLARGO, INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.

Material Agreements March 25, 2026, 7:59 PM ET

BIOLARGO, INC. entered into Purchase Agreement with CLEARTHINK CAPITAL PARTNERS, LLC valued at up to $10.0 million (effective 2026-03-20).

“On March 20, 2026, BioLargo, Inc. (the “Company” or “we”) entered into a purchase agreement dated as of March 20, 2026 (the “Purchase Agreement”), and a registration rights agreement dated as of March 20, 2026 (the “Registration Rights Agreement”), with CLEARTHINK CAPITAL PARTNERS, LLC (“Clearthink”), pursuant to which Clearthink has committed to purchase up to $10.0 million of the Company’s common stock”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.